Friday, January 10, 2014
NEA Bolsters Pharma Industry Expertise With New Venture Partner
Menlo Park-based venture investor New Enterprise Associates said this week that it has hired on Elliot Sigal, M.D., Ph.D., as a new Venture Partner and Senior Advisor, significantly bolstering the company's expertise in the pharmaceuticals industry. Sigal was previously EVP and a Director at Bristol-Myers Squibb, having been the biotech giant's Chief Scientific Officer and President of R&D. Sigal also sits on the boards of Mead Johnson Nuritoin Company, among other companies.